We identified five COPD dominant genes (APC, CSMD3, POLE, FGF3, and CCND1), and further validated that mutations in these five genes led to more severe clinical manifestations in NSCLC patients. This evidence concerns the gene CCND1 and non-small cell lung carcinoma.